Any feedback?
Literature summary for 3.5.2.2 extracted from
- Pyrimidine base catabolism in Pseudomonas putida biotype B (2001), Antonie van Leeuwenhoek, 80, 163-167.
Inhibitors
| Inhibitors | Comment | Organism | Structure |
|---|---|---|---|
| chloramphenicol | 10.5fold reduced activity in chloramphenicol-treated cells | Pseudomonas putida |  |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Pseudomonas putida | - |
biotype B, strain ATCC 17536 | - |
Specific Activity [micromol/min/mg]
| Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
|---|---|---|---|
| 0.00569 | - |
at 30°C | Pseudomonas putida |
Substrates and Products (Substrate)
| Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
|---|---|---|---|---|---|---|
| dihydrothymine + H2O | - |
Pseudomonas putida | N-carbamoyl-beta-aminoisobutyric acid | - |
? | |
| dihydrouracil + H2O | - |
Pseudomonas putida | N-carbamoyl-beta-alanine | - |
? | |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
